Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
By: PR Newswire Association LLC. - 05 Feb 2024 | Back to overview list |
|||||||||||||||||||||||||||||||||||||||||||||||||||
Zinzino group revenue increased with a total of 15%, compared with the previous year. GOTHENBURG, Sweden, Feb. 5, 2024 /PRNewswire/ -- The revenue in January for Zinzino's sales markets increased by 17% and amounted to SEK 140.2 (120.3) million. Faun Pharma's external sales decreased by 11% and amounted to SEK 8.1 (9.1) million. Overall, the Group increased revenues by 15% to SEK 148.3 (129.4) million compared with the previous year. Revenues were distributed as follows:
Countries in regions: -The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden For more information: Pictures for publication free of charge: marketing@zinzino.com Certified Adviser: Carnegie Investment Bank AB (publ) The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-january-2024-302053390.html |
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |